![]() ![]() However, optimal management in the perioperative period is not well established. Immunocompromised patients are at higher risk of surgical site infection and wound complications. This review will explore the natural history of abdominal wall complications in the kidney transplant setting, with a special focus on wound dehiscence and incisional hernia, with a particular emphasis on risk factors, clinical characteristics and treatment. Biologic mesh could be an attractive alternative in patients with graft exposition or infection. Mesh repair is considered the gold standard for the treatment of IH, since it is associated with a low rate of postoperative complications and an acceptable rate of recurrence. Most patients require surgical treatment, either open or laparoscopic. Incisional hernia (IH) may affect 1.1–18% of kidney transplant recipients. However, for deep dehiscence involving the fascial layer with concomitant infection, surgical treatment and/or negative pressure wound therapy may be required. ![]() Wound dehiscence usually does not require surgical intervention. Many patient-related risk factors have been suggested, including older age, obesity and smoking, but kidney transplant recipients have an additional risk related to the use of immunosuppression. Abdominal wall complications have an overall incidence of 7.7–21%. Abdominal wall complications are common after kidney transplantation, and although they have a minor impact on patient and graft survival, they increase the patient's morbidity and may have an impact on quality of life. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |